AMANDA STERLING: Open Payments
NPI 1851046734 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 14 payments from 10 companies in 2025. Trend: 2023 $86 · 2024 $146 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
| Medline Industries LP | 1 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $32 |
| Medtronic, Inc. | 1 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| Heron Therapeutics, Inc. | 1 | $24 |
| COLOPLAST CORP | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Xolair, Veozah, MYFEMBREE, PERCLOT, TRUCLEAR, ZYNRELEF, Altis, ABRYSVO.
Industry payments across MS — which companies pay providers there.
